Fondazione Ricerca e Innovazione Cardiovascolare
- Address
- Via Ettore Ponti 49
Sponsor Overview
Specializations
Coronary artery disease and post-PCI care
Research activity is centered on patients with stable or unstable coronary syndromes after successful percutaneous coronary intervention, with attention to long-term treatment choices in this setting.
- Coronary syndromes
- Post-PCI antithrombotic management
- Ischaemic risk reduction
The sponsor’s funded research reflects a clinical interest in optimizing secondary prevention for patients recovering from coronary revascularisation.
Antiplatelet therapy strategies
The trial portfolio focuses on comparing single antiplatelet therapy and dual antiplatelet therapy in the context of coronary disease, with emphasis on balancing protection from thrombotic events and treatment-related harm.
- Single antiplatelet therapy
- Dual antiplatelet therapy
- Thrombotic event prevention
Interest extends to treatment selection in older patients and in those with heightened vulnerability to adverse effects from intensified antithrombotic treatment.
Bleeding risk and clinical safety
A major therapeutic focus is the reduction of bleeding complications while maintaining cardiovascular protection, particularly in patients at increased risk of haemorrhagic events.
- Clinically relevant bleeding
- High bleeding risk patients
- Net clinical benefit
The funded research examines safety outcomes alongside cardiovascular efficacy, reflecting an interest in treatment regimens that are better suited to fragile patient groups.
Cardiovascular outcomes and event prevention
Clinical outcomes of interest include major adverse cardiovascular events and composite measures that capture both ischaemic and bleeding endpoints, supporting a broad assessment of patient benefit after coronary intervention.
- Major adverse cardiovascular events
- Composite clinical outcomes
- Secondary prevention
This area of research aligns with efforts to refine antithrombotic care for older adults and other patients in whom treatment intensity must be carefully matched to risk.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Single Versus Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly or High Bleeding Risk Patients Post-PCI with Drug-Coated Balloons |  Belgium Italy Luxembourg Spain | Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 19 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
19 centres- Address
- Via Trabucco 180, 90146 Palermo
- Address
- Via Felice Migliori 1, 87100 Cosenza
- Address
- viale Antonio Gramsci 14, 43126 Parma
- Address
- Via Senese 169, 58100 Arezzo
- Address
- Chaussée de Bruxelles 140, 6042 Charleroi
- Address
- Estrada Clara Campoamor N 341, 36312 Vigo
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Fondazione Ricerca e Innovazione Cardiovascolare.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.